End-of-day quote
Shenzhen S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
40.1
CNY
|
+1.75%
|
|
+6.88%
|
+14.54%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
27,656
|
33,157
|
32,307
|
27,456
|
28,292
|
32,312
|
-
|
-
|
Enterprise Value (EV)
1 |
20,161
|
25,123
|
25,850
|
20,652
|
21,099
|
25,274
|
26,367
|
25,046
|
P/E ratio
|
24.2
x
|
22.1
x
|
21.2
x
|
15.9
x
|
16.7
x
|
17.3
x
|
15.1
x
|
14.2
x
|
Yield
|
3.41%
|
3.09%
|
3.23%
|
4.93%
|
3.86%
|
4.12%
|
4.62%
|
5.17%
|
Capitalization / Revenue
|
2.95
x
|
3.15
x
|
2.68
x
|
2.17
x
|
2.28
x
|
2.44
x
|
2.23
x
|
2.16
x
|
EV / Revenue
|
2.15
x
|
2.39
x
|
2.14
x
|
1.64
x
|
1.7
x
|
1.91
x
|
1.82
x
|
1.67
x
|
EV / EBITDA
|
9.54
x
|
9.96
x
|
10.6
x
|
6.85
x
|
5.85
x
|
8.15
x
|
7.72
x
|
6.58
x
|
EV / FCF
|
14,705,388
x
|
16,540,506
x
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2.82
x
|
3.16
x
|
2.84
x
|
2.19
x
|
2.3
x
|
2.51
x
|
2.35
x
|
2.26
x
|
Nbr of stocks (in thousands)
|
934,763
|
938,721
|
934,387
|
933,588
|
923,938
|
922,299
|
-
|
-
|
Reference price
2 |
33.70
|
40.50
|
40.21
|
32.48
|
35.01
|
40.10
|
40.10
|
40.10
|
Announcement Date
|
3/25/20
|
3/22/21
|
3/28/22
|
3/30/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
9,385
|
10,520
|
12,064
|
12,630
|
12,430
|
13,252
|
14,474
|
14,981
|
EBITDA
1 |
2,114
|
2,522
|
2,431
|
3,014
|
3,605
|
3,101
|
3,418
|
3,809
|
EBIT
1 |
1,730
|
2,500
|
2,267
|
2,351
|
2,415
|
2,726
|
2,997
|
3,176
|
Operating Margin
|
18.43%
|
23.77%
|
18.79%
|
18.61%
|
19.43%
|
20.57%
|
20.71%
|
21.2%
|
Earnings before Tax (EBT)
1 |
1,728
|
2,489
|
2,246
|
2,331
|
2,383
|
2,846
|
3,134
|
3,339
|
Net income
1 |
1,303
|
1,715
|
1,776
|
1,909
|
1,954
|
2,158
|
2,450
|
2,546
|
Net margin
|
13.88%
|
16.3%
|
14.72%
|
15.12%
|
15.72%
|
16.29%
|
16.93%
|
16.99%
|
EPS
2 |
1.390
|
1.830
|
1.900
|
2.040
|
2.100
|
2.318
|
2.660
|
2.830
|
Free Cash Flow
|
1,371
|
1,519
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
14.61%
|
14.44%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
64.84%
|
60.22%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
105.23%
|
88.57%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
1.150
|
1.250
|
1.300
|
1.600
|
1.350
|
1.654
|
1.851
|
2.075
|
Announcement Date
|
3/25/20
|
3/22/21
|
3/28/22
|
3/30/23
|
3/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
2,695
|
3,479
|
2,824
|
3,186
|
3,141
|
3,413
|
3,277
|
2,965
|
2,775
|
3,243
|
3,458
|
3,384
|
3,112
|
3,529
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
392.1
|
723.5
|
601.7
|
547.5
|
477.9
|
738.3
|
690.1
|
558.8
|
427.9
|
757.9
|
725.7
|
603.7
|
538.2
|
842
|
Operating Margin
|
14.55%
|
20.8%
|
21.31%
|
17.18%
|
15.21%
|
21.63%
|
21.06%
|
18.85%
|
15.42%
|
23.37%
|
20.99%
|
17.84%
|
17.29%
|
23.86%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
0.3500
|
0.5900
|
0.5000
|
0.5200
|
0.4300
|
0.6200
|
0.6000
|
0.5000
|
0.3800
|
0.6500
|
0.5200
|
0.5200
|
0.5550
|
0.6800
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/28/22
|
4/21/22
|
8/9/22
|
10/25/22
|
3/30/23
|
4/20/23
|
8/23/23
|
10/24/23
|
3/28/24
|
4/23/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
7,495
|
8,034
|
6,457
|
6,804
|
7,193
|
7,037
|
5,944
|
7,265
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
1,371
|
1,519
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
12%
|
14.9%
|
14.1%
|
14.3%
|
14%
|
15%
|
16.1%
|
16.2%
|
ROA (Net income/ Total Assets)
|
7.36%
|
8.89%
|
8.27%
|
8.08%
|
7.83%
|
8.6%
|
9.1%
|
9.6%
|
Assets
1 |
17,707
|
19,284
|
21,482
|
23,619
|
24,957
|
25,097
|
26,927
|
26,517
|
Book Value Per Share
2 |
11.90
|
12.80
|
14.20
|
14.80
|
15.20
|
16.00
|
17.00
|
17.80
|
Cash Flow per Share
2 |
1.890
|
2.290
|
2.030
|
2.960
|
3.520
|
3.050
|
2.840
|
-
|
Capex
1 |
396
|
642
|
1,300
|
937
|
806
|
996
|
903
|
1,030
|
Capex / Sales
|
4.22%
|
6.1%
|
10.78%
|
7.42%
|
6.48%
|
7.51%
|
6.24%
|
6.88%
|
Announcement Date
|
3/25/20
|
3/22/21
|
3/28/22
|
3/30/23
|
3/28/24
|
-
|
-
|
-
|
Last Close Price
40.1
CNY Average target price
41.14
CNY Spread / Average Target +2.59% Consensus |
1st Jan change
|
Capi.
|
---|
| +14.54% | 4.38B | | +32.50% | 664B | | +29.29% | 567B | | -6.93% | 354B | | +19.86% | 330B | | +4.70% | 286B | | +13.79% | 234B | | +4.93% | 199B | | -9.78% | 196B | | -4.93% | 148B |
Other Pharmaceuticals
|